Literature DB >> 11896563

National Cancer Institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: role of COX-dependent and -independent mechanisms.

Daniel H Hwang1, Victor Fung, Andrew J Dannenberg.   

Abstract

A workshop, "Chemopreventive properties of nonsteroidal anti-inflammatory drugs (NSAIDs): Role of COX-dependent and -independent mechanisms," sponsored by the Chemical and Physical Carcinogenesis Branch, Division of Cancer Biology of the National Cancer Institute, was held in Rockville, Maryland, on January 8, 2001. The workshop was composed of two parts: oral presentations by a series of speakers, and a group discussion of preselected topics.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11896563      PMCID： PMC1550326          DOI： 10.1038/sj.neo.7900226

Source DB:  PubMed          Journal:  Neoplasia        ISSN： 1476-5586            Impact factor:   5.715


  44 in total

1.  Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.

Authors:  S K Boolbol; A J Dannenberg; A Chadburn; C Martucci; X J Guo; J T Ramonetti; M Abreu-Goris; H L Newmark; M L Lipkin; J J DeCosse; M M Bertagnolli
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

2.  Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated protein.

Authors:  B A Ballif; N V Mincek; J T Barratt; M L Wilson; D L Simmons
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

3.  Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs.

Authors:  J M Lehmann; J M Lenhard; B B Oliver; G M Ringold; S A Kliewer
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

4.  Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas.

Authors:  H Achiwa; Y Yatabe; T Hida; T Kuroishi; K Kozaki; S Nakamura; M Ogawa; T Sugiura; T Mitsudomi; T Takahashi
Journal:  Clin Cancer Res       Date:  1999-05       Impact factor: 12.531

Review 5.  Colorectal cancer and nonsteroidal anti-inflammatory drugs.

Authors:  W E Smalley; R N DuBois
Journal:  Adv Pharmacol       Date:  1997

6.  Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.

Authors:  M Huang; M Stolina; S Sharma; J T Mao; L Zhu; P W Miller; J Wollman; H Herschman; S M Dubinett
Journal:  Cancer Res       Date:  1998-03-15       Impact factor: 12.701

7.  Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

Authors:  M Oshima; J E Dinchuk; S L Kargman; H Oshima; B Hancock; E Kwong; J M Trzaskos; J F Evans; M M Taketo
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

8.  Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production.

Authors:  M Huang; S Sharma; J T Mao; S M Dubinett
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

9.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

Authors:  M Tsujii; R N DuBois
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

10.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.

Authors:  F M Giardiello; S R Hamilton; A J Krush; S Piantadosi; L M Hylind; P Celano; S V Booker; C R Robinson; G J Offerhaus
Journal:  N Engl J Med       Date:  1993-05-06       Impact factor: 91.245
View more
  14 in total

1.  Chemopreventive effects of non-steroidal anti-inflammatory drugs in early neoplasm of experimental colorectal cancer: an apoptosome study.

Authors:  Vivek Vaish; Lalita Tanwar; Jasmeet Kaur; Sankar Nath Sanyal
Journal:  J Gastrointest Cancer       Date:  2011-12

2.  Cyclooxygenase-2 expression in hamster and human pancreatic neoplasia.

Authors:  Pamela L Crowell; C Max Schmidt; Michele T Yip-Schneider; Jesse J Savage; Dean A Hertzler; William O Cummings
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

3.  A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.

Authors:  Jason D Whitt; Nan Li; Heather N Tinsley; Xi Chen; Wei Zhang; Yonghe Li; Bernard D Gary; Adam B Keeton; Yaguang Xi; Ashraf H Abadi; William E Grizzle; Gary A Piazza
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-03

4.  R(+)-methanandamide elicits a cyclooxygenase-2-dependent mitochondrial apoptosis signaling pathway in human neuroglioma cells.

Authors:  Karin Eichele; Ulrike Weinzierl; Robert Ramer; Kay Brune; Burkhard Hinz
Journal:  Pharm Res       Date:  2006-11-08       Impact factor: 4.200

5.  The role of NF-κB and PPARγ in experimentally induced colorectal cancer and chemoprevention by cyclooxygenase-2 inhibitors.

Authors:  Vivek Vaish; Lalita Tanwar; Sankar Nath Sanyal
Journal:  Tumour Biol       Date:  2010-06-01

6.  Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene.

Authors:  Maria Elena Martinez; Thomas G O'Brien; Kimberly E Fultz; Naveen Babbar; Hagit Yerushalmi; Ning Qu; Yongjun Guo; David Boorman; Janine Einspahr; David S Alberts; Eugene W Gerner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

7.  Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway.

Authors:  Mi-Heon Lee; Puja Kachroo; Paul C Pagano; Jane Yanagawa; Gerald Wang; Tonya C Walser; Kostyantyn Krysan; Sherven Sharma; Maie St John; Steven M Dubinett; Jay M Lee
Journal:  J Cancer Sci Ther       Date:  2014-11-15

8.  Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.

Authors:  Robert Ramer; Udo Walther; Philipp Borchert; Stefan Laufer; Michael Linnebacher; Burkhard Hinz
Journal:  J Lipid Res       Date:  2013-08-12       Impact factor: 5.922

9.  Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer.

Authors:  J C Wilson; L J Murray; C M Hughes; A Black; L A Anderson
Journal:  Br J Cancer       Date:  2013-02-28       Impact factor: 7.640

Review 10.  Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer.

Authors:  Xian-Zhong Ding; Rene Hennig; Thomas E Adrian
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.